STAND. COM. REP. NO. 2357

 

Honolulu, Hawaii

                  

 

RE:    S.B. No. 2228

       S.D. 1

 

 

 

Honorable Shan S. Tsutsui

President of the Senate

Twenty-Sixth State Legislature

Regular Session of 2012

State of Hawaii

 

Sir:

 

     Your Committee on Health, to which was referred S.B. No. 2228 entitled:

 

"A BILL FOR AN ACT RELATING TO PSEUDOEPHEDRINE,"

 

begs leave to report as follows:

 

     The purpose and intent of this measure is to establish an electronic tracking system for the sale of products containing pseudoephedrine.

 

     Your Committee received testimony in support of this measure from the Hawaii Food Industry Association.  Your Committee received comments on this measure from the Department of Public Safety and the Department of the Attorney General.

 

     Your Committee finds that the electronic tracking system provided for under this measure will allow for real-time approval or denial of pseudoephedrine purchases at the point of sale.  Your Committee further finds that efforts to improve the tracking and purchasing of pseudoephedrine are in the interests of the State and its efforts to inhibit the spread of illegal narcotics such as methamphetamine.

 

     Your Committee has amended this measure by:

 

     (1)  Requiring the Department of Public Safety Narcotics Enforcement Division to establish the electronic tracking system for pseudoephedrine sales in conjunction with the State's existing narcotics tracking system beginning no later than January 1, 2015; and

 

     (2)  Making technical, nonsubstantive amendments for the purposes of clarity and consistency.

 

     As affirmed by the record of votes of the members of your Committee on Health that is attached to this report, your Committee is in accord with the intent and purpose of S.B. No. 2228, as amended herein, and recommends that it pass Second Reading in the form attached hereto as S.B. No. 2228, S.D. 1, and be referred to the Committee on Commerce and Consumer Protection.

 

Respectfully submitted on behalf of the members of the Committee on Health,

 

		____________________________ JOSH GREEN, M.D., Chair